EP300 and myelodysplastic syndrome: To investigate the role of p300 in MDS progression driven by Tet2 deficiency, we crossed Tet2-deficient (Tet2–/– and Tet2+/–) mice with hematopoietic-specific conditional knockout Ep300 mice and generated primary and transplantation mouse models.